AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 116 filers reported holding AXSOME THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is 0.52 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,300,810 | +16.6% | 18,102 | +25.2% | 0.24% | +4.3% |
| Q4 2022 | $1,115,146 | -52.0% | 14,458 | -72.2% | 0.23% | -54.3% |
| Q3 2022 | $2,324,000 | +18.6% | 52,092 | +1.8% | 0.50% | +5.6% |
| Q2 2022 | $1,959,000 | -18.7% | 51,160 | +74.6% | 0.48% | -10.3% |
| Q2 2020 | $2,410,000 | -45.5% | 29,293 | -61.1% | 0.53% | -61.2% |
| Q1 2020 | $4,426,000 | -40.2% | 75,235 | +5.1% | 1.37% | -15.6% |
| Q4 2019 | $7,396,000 | +182.0% | 71,556 | -44.8% | 1.63% | +134.4% |
| Q3 2019 | $2,623,000 | -31.4% | 129,584 | -12.7% | 0.69% | -25.8% |
| Q2 2019 | $3,823,000 | +18.2% | 148,471 | -34.7% | 0.94% | +17.9% |
| Q1 2019 | $3,234,000 | – | 227,241 | – | 0.79% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 788,263 | $35,172,000 | 44.43% |
| Fairmount Funds Management LLC | 1,896,647 | $84,628,000 | 14.88% |
| ACT CAPITAL MANAGEMENT, LLC | 73,000 | $3,257,000 | 4.50% |
| Ghost Tree Capital, LLC | 300,000 | $13,386,000 | 3.76% |
| Ikarian Capital, LLC | 407,600 | $18,188,000 | 3.62% |
| Paradigm Biocapital Advisors LP | 520,080 | $23,206,000 | 3.09% |
| MORGAN JESS S & CO INC | 78,895 | $3,520,000 | 3.06% |
| PFM Health Sciences, LP | 1,659,733 | $74,057,000 | 2.68% |
| RTW INVESTMENTS, LP | 1,882,164 | $83,982,000 | 1.94% |
| Ghost Tree Capital, LLC | 150,000 | $6,693,000 | 1.88% |